T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.97B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.37B |
| 3 |
lululemon athletica
LULU
|
+$1.32B |
| 4 |
Spotify
SPOT
|
+$1.28B |
| 5 |
ServiceNow
NOW
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$3.41B |
| 2 |
Northrop Grumman
NOC
|
+$2.36B |
| 3 |
Microsoft
MSFT
|
+$2.2B |
| 4 |
McDonald's
MCD
|
+$1.85B |
| 5 |
Intercontinental Exchange
ICE
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.34% |
| 2 | Healthcare | 16.78% |
| 3 | Financials | 13.77% |
| 4 | Consumer Discretionary | 12.98% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Granite Construction
GVA
$5.45B
| $1.01M | ﹤0.01% |
36,694
+6,662
| +22% | +$189K |
|
1877
United Natural Foods
UNFI
$2.92B
| $1.01M | ﹤0.01% |
115,838
+84,065
| +265% | +$678K |
|
1878
Heron Therapeutics
HRTX
$62.8M
| $1.01M | ﹤0.01% |
42,970
-17,055
| -28% | -$377K |
|
|
TWOU
1879
DELISTED
2U Inc
TWOU
| $1.01M | ﹤0.01% |
1,398
-1,345
| -49% | -$837K |
|
|
FOE
1880
DELISTED
Ferro Corporation
FOE
| $1M | ﹤0.01% |
67,610
+3,240
| +5% | +$41.8K |
|
1881
Strategy Inc
MSTR
$38B
| $1M | ﹤0.01% |
70,280
+3,280
| +5% | +$48.8K |
|
1882
First Busey Corp
BUSE
$2.58B
| $997K | ﹤0.01% |
36,262
+2,028
| +6% | +$53.5K |
|
1883
E.W. Scripps
SSP
$315M
| $997K | ﹤0.01% |
63,462
+17,568
| +38% | +$251K |
|
1884
TTM Technologies
TTMI
$14.8B
| $996K | ﹤0.01% |
66,160
+5,525
| +9% | +$72.6K |
|
1885
FormFactor
FORM
$10.3B
| $994K | ﹤0.01% |
38,263
+9,014
| +31% | +$203K |
|
|
FINV
1886
FinVolution Group
FINV
$1.07B
| $993K | ﹤0.01% |
374,763
-50,740
| -12% | -$135K |
|
|
HEES
1887
DELISTED
H&E Equipment Services
HEES
| $990K | ﹤0.01% |
29,615
+1,269
| +4% | +$41.2K |
|
1888
Peapack-Gladstone Financial
PGC
$820M
| $988K | ﹤0.01% |
31,966
+3,629
| +13% | +$107K |
|
|
MGLN
1889
DELISTED
Magellan Health Services, Inc.
MGLN
| $985K | ﹤0.01% |
12,584
+864
| +7% | +$60.8K |
|
|
ECHO
1890
EchoStar
ECHO
$26.6B
| $981K | ﹤0.01% |
22,661
+1,518
| +7% | +$60.9K |
|
|
HTGM
1891
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $981K | ﹤0.01% |
7,761
-351
| -4% | -$47.5K |
|
|
NXGN
1892
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $978K | ﹤0.01% |
60,852
+2,179
| +4% | +$36K |
|
|
PRMW
1893
DELISTED
Primo Water Corporation
PRMW
| $978K | ﹤0.01% |
87,124
+20,188
| +30% | +$224K |
|
1894
NETSCOUT
NTCT
$2.9B
| $977K | ﹤0.01% |
40,590
+2,787
| +7% | +$65.9K |
|
|
BRKL
1895
DELISTED
Brookline Bancorp
BRKL
| $974K | ﹤0.01% |
59,148
+3,112
| +6% | +$49K |
|
1896
Kulicke & Soffa
KLIC
$5.02B
| $971K | ﹤0.01% |
35,700
| – | – |
|
1897
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $966K | ﹤0.01% |
3,000
-6,000
| -67% | -$1.85M |
|
1898
Coca-Cola Europacific Partners
CCEP
$47.2B
| $963K | ﹤0.01% |
18,931
+1,470
| +8% | +$77.4K |
|
1899
TFS Financial
TFSL
$4.93B
| $959K | ﹤0.01% |
48,755
+1,776
| +4% | +$34.3K |
|
|
KAMN
1900
DELISTED
Kaman Corp
KAMN
| $956K | ﹤0.01% |
14,507
-604
| -4% | -$37.7K |
|
Similar funds
T. Rowe Price Associates's Q4 2019 Portfolio in Review
As of Q4 2019, T. Rowe Price Associates held 2,605 positions worth $771B, up 9.2% from $706B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
T. Rowe Price Associates's Q4 2019 filing shows 87 new, 1,561 increased, 802 reduced and 81 closed positions. Its largest new stake was XP: 7,905,172 shares worth $305M. The largest sale was Boeing, an estimated $3.41B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2019 buy was XP: 7,905,172 shares worth $305M.
- T. Rowe Price Associates added most to Apple in Q4 2019, an estimated $6.97B increase.
- T. Rowe Price Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $3.41B.
- T. Rowe Price Associates fully exited Viacom Inc. Class B in Q4 2019, selling an estimated $204M.
- T. Rowe Price Associates's ten largest holdings make up 22% of its $771B portfolio in Q4 2019.
- T. Rowe Price Associates opened 87 new positions and closed 81 in Q4 2019.
- T. Rowe Price Associates's portfolio value rose 9.2% quarter-over-quarter to $771B.
Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.